BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21404147)

  • 1. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders.
    Márquez M; Arenoso H; Caruso N
    Actas Esp Psiquiatr; 2011; 39(2):88-94. PubMed ID: 21404147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
    Sheehan DV; Sheehan KH; Raj BA
    Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 5. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
    J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders.
    Béchir M; Schwegler K; Chenevard R; Binggeli C; Caduff C; Büchi S; Buddeberg C; Lüscher TF; Noll G
    Auton Neurosci; 2007 Jul; 134(1-2):69-73. PubMed ID: 17363337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
    Pecknold J; Luthe L; Munjack D; Alexander P
    J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
    Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
    J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
    Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 17. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL
    Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
    [No Abstract]   [Full Text] [Related]  

  • 19. Alprazolam treatment for panic disorders.
    Alexander PE; Alexander DD
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.